Related references
Note: Only part of the references are listed.Antifungal activity of two oxadiazole compounds for the paracoccidioidomycosis treatment
Franciele Abigail Vilugron Rodrigues-Vendramini et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Two New 1,3,4-Oxadiazoles With Effective Antifungal Activity Against Candida albicans
Isis Regina Grenier Capoci et al.
FRONTIERS IN MICROBIOLOGY (2019)
In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates
Renata Cougo Moraes et al.
PHARMACEUTICAL BIOLOGY (2017)
Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients
Vladimir Hrabovsky et al.
FOLIA MICROBIOLOGICA (2017)
A new small-molecule KRE2 inhibitor against invasive Candida parapsilosis infection
Tania P. Salci et al.
FUTURE MICROBIOLOGY (2017)
Synergistic anticandidal activity of menthol in combination with itraconazole and nystatin against clinical Candida glabrata and Candida krusei isolates
Aghil Sharifzadeh et al.
MICROBIAL PATHOGENESIS (2017)
Epidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013
Gabriel Motoa et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2017)
The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans
Luna S. Joffe et al.
FRONTIERS IN MICROBIOLOGY (2017)
Antifungal mechanism of the combination of Cinnamomum verum and Pelargonium graveolens essential oils with fluconazole against pathogenic Candida strains
Rym Essid et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Targeting the Homoserine Dehydrogenase of Paracoccidioides Species for Treatment of Systemic Fungal Infections
Mariane C. Bagatin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Studying the Prevalence, Species Distribution, and Detection of In vitro Production of Phospholipase from Candida Isolated from Cases of Invasive Candidiasis
Yukti Sharma et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2017)
Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-2012
Sara Strollo et al.
EMERGING INFECTIOUS DISEASES (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia
Masahiro Ishikane et al.
PLOS ONE (2016)
Bioactive Organocopper Compound from Pseudomonas aeruginosa Inhibits the Growth of Xanthomonas citri subsp citri
Admilton G. de Oliveira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
Olivier Leroy et al.
ANNALS OF INTENSIVE CARE (2016)
Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program
Andre Mario Doi et al.
PLOS ONE (2016)
Understanding the Antifungal Mechanism of Ag@ZnO Core-shell Nanocomposites against Candida krusei
Bhaskar Das et al.
SCIENTIFIC REPORTS (2016)
Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy
A. Forastiero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Novel synthetic anti-fungal tripeptide effective against Candida krusei
K. Gill et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Structure based virtual screening to discover putative drug candidates: Necessary considerations and successful case studies
Mohd Danishuddin et al.
METHODS (2015)
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Maurizio Sanguinetti et al.
MYCOSES (2015)
Synergistic Antifungal Activity of Berberine Derivative B-7b and Fluconazole
Li Ping Li et al.
PLOS ONE (2015)
Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms
Takao Watamoto et al.
FRONTIERS IN MICROBIOLOGY (2015)
A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance
Christopher G. Pierce et al.
NPJ BIOFILMS AND MICROBIOMES (2015)
Development of echinocandin resistance in Candida krusei isolates following exposure to micafungin and caspofungin in a BM transplant unit
E. Tavernier et al.
BONE MARROW TRANSPLANTATION (2015)
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus
Ana Karina Rodrigues Abadio et al.
PLOS ONE (2015)
Clinical significance of the isolation of Candida species from hospitalized patients
Yankee C. Magalhaes et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2015)
Global trends in the distribution of Candida species causing candidemia
J. Guinea
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period
Arnaldo L. Colombo et al.
INTENSIVE CARE MEDICINE (2014)
In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
Sarah Sze Wah Wong et al.
PLOS ONE (2014)
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Terry Roemer et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil
Marcos Paulo Wille et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans
Mohd Sajjad Ahmad Khan et al.
MEDICAL MYCOLOGY (2012)
Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model
Alireza Khodavandi et al.
FEMS MICROBIOLOGY LETTERS (2011)
The Interaction between Candida krusei and Murine Macrophages Results in Multiple Outcomes, Including Intracellular Survival and Escape from Killing
Rocio Garcia-Rodas et al.
INFECTION AND IMMUNITY (2011)
Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis
Michail S. Lionakis et al.
JOURNAL OF INNATE IMMUNITY (2011)
Discovery and characterization of β-1,6-glucan inhibitors
Akihiro Kitamura
EXPERT OPINION ON DRUG DISCOVERY (2010)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
In vitro synergistic effects of metergoline and antifungal agents against Candida krusei
K. Kang et al.
MYCOSES (2010)
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei
J. Majithiya et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Amphotericin B: side effects and toxicity
Rafael Laniado-Laborin et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
Candida krusei, a multidrug-resistant opportunistic fungal pathogen:: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Seminational surveillance of fungemia in Denmark: Notably high rates of fungemia and numbers of isolates with reduced azole susceptibility
MC Arendrup et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Assessing in vitro combinations of antifungal drugs against yeasts and filamentous fungi:: comparison of different drug interaction models
J Meletiadis et al.
MEDICAL MYCOLOGY (2005)
Candida krusei fungaemia:: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital
P Muñoz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Guidelines for treatment of candidiasis
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2004)
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species
RE Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Physiological functions of thioredoxin and thioredoxin reductase
ESJ Arnér et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
